Latest news Image: Bru-nO/PixabayEASL 2020: NAFLDFatty liver disease affects one in four in Europe, study estimates. Professor Heiner Wedemeyer of Essen University Hospital.EASL 2020: Hepatitis DBulevirtide shows promise as maintenance therapy for hepatitis D. Andrey_Popov/Shutterstock.comNAFLDDiabetes raises the risk of liver damage in people with HIV. infohep news Experimental treatments for NASH/NAFLD Experimental NASH treatments: Gilead candidates miss primary endpoint but show some benefits Liz Highleyman / 20 October 2020 Combinations of experimental drugs for non-alcoholic steatohepatitis (NASH) failed to meet a study's primary endpoint by significantly improving liver fibrosis without worsening NASH, but one combo in particular - firsocostat plus cilofexor ... Hepatitis C elimination Test and treat reduces hepatitis C by 83% in Melbourne gay men with HIV Keith Alcorn / 13 October 2020 Testing and treatment for hepatitis C in gay and bisexual men with HIV in Melbourne reduced the prevalence of the infection by 83% between 2012 and 2019, Australian researchers report ... View all infohep news Editors' picks from other sources Hepatitis C eradication in Korea 10 years behind WHO target Korea Biomedical News / 13 October 2020 Why Don’t We Have a Hepatitis C Vaccine Yet? Inside Science / 13 October 2020 Over 10 million patients, India’s 10-year Hepatitis C elimination deadline seems far Indian Express / 13 October 2020 View all news from other sources Conference news More conference news Noticeboard ILC 2016 webinar: watch again More noticeboard posts Email updates Sign up for our monthly bulletins Sign up today Other pages in this section Latest news All the news Conference news Noticeboard Email bulletins News feeds